Seiki Kiriyama
Overview
Explore the profile of Seiki Kiriyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
2969
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kato H, Takada T, Strasberg S, Isaji S, Sano K, Yoshida M, et al.
J Hepatobiliary Pancreat Sci
. 2023 Oct;
31(1):12-24.
PMID: 37882430
Background/purpose: The aim of this study was to clarify the clinical characteristics of acute cholangitis (AC) after bilioenteric anastomosis and stent-related AC in a multi-institutional retrospective study, and validate the...
2.
Takada T, Isaji S, Mayumi T, Yoshida M, Takeyama Y, Itoi T, et al.
J Hepatobiliary Pancreat Sci
. 2022 Apr;
29(10):1057-1083.
PMID: 35388634
Background: In preparing the Japanese (JPN) guidelines for the management of acute pancreatitis 2021, the committee focused the issues raised by the results of nationwide epidemiological survey in 2016 in...
3.
Takada T, Isaji S, Yoshida M, Horiguchi A, Ando H, Miyakawa S, et al.
J Hepatobiliary Pancreat Sci
. 2021 Nov;
29(5):505-520.
PMID: 34758180
Background: Socratic method, which is an educational method to promote critical thinking through a dialogue, has never been practiced in a large number of people at the academic societies. Methods:...
4.
Toyoda H, Yasuda S, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, et al.
GastroHep
. 2020 Aug;
2(5):247-252.
PMID: 32837333
Background: The current coronavirus disease 2019 (COVID-19) pandemic has strongly influenced many aspects of the medical care, including cancer surveillance. Aims: We investigated how the COVID-19 pandemic influenced surveillance for...
5.
Yasuda H, Kataoka K, Takeyama Y, Takeda K, Ito T, Mayumi T, et al.
World J Gastroenterol
. 2019 Jan;
25(1):107-117.
PMID: 30643362
Background: Rapid urinary trypsinogen-2 dipstick test and levels of urinary trypsinogen-2 and trypsinogen activation peptide (TAP) concentration have been reported as prognostic markers for the diagnosis of acute pancreatitis. Aim:...
6.
Mayumi T, Okamoto K, Takada T, Strasberg S, Solomkin J, Schlossberg D, et al.
J Hepatobiliary Pancreat Sci
. 2017 Nov;
25(1):96-100.
PMID: 29090868
Management bundles that define items or procedures strongly recommended in clinical practice have been used in many guidelines in recent years. Application of these bundles facilitates the adaptation of guidelines...
7.
Gomi H, Solomkin J, Schlossberg D, Okamoto K, Takada T, Strasberg S, et al.
J Hepatobiliary Pancreat Sci
. 2017 Nov;
25(1):3-16.
PMID: 29090866
Antimicrobial therapy is a mainstay of the management for patients with acute cholangitis and/or cholecystitis. The Tokyo Guidelines 2018 (TG18) provides recommendations for the appropriate use of antimicrobials for community-acquired...
8.
Okamoto K, Suzuki K, Takada T, Strasberg S, Asbun H, Endo I, et al.
J Hepatobiliary Pancreat Sci
. 2017 Oct;
25(1):55-72.
PMID: 29045062
We propose a new flowchart for the treatment of acute cholecystitis (AC) in the Tokyo Guidelines 2018 (TG18). Grade III AC was not indicated for straightforward laparoscopic cholecystectomy (Lap-C). Following...
9.
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)
Yokoe M, Hata J, Takada T, Strasberg S, Asbun H, Wakabayashi G, et al.
J Hepatobiliary Pancreat Sci
. 2017 Oct;
25(1):41-54.
PMID: 29032636
The Tokyo Guidelines 2013 (TG13) for acute cholangitis and cholecystitis were globally disseminated and various clinical studies about the management of acute cholecystitis were reported by many researchers and clinicians...
10.
Kiriyama S, Kozaka K, Takada T, Strasberg S, Pitt H, Gabata T, et al.
J Hepatobiliary Pancreat Sci
. 2017 Oct;
25(1):17-30.
PMID: 29032610
Although the diagnostic and severity grading criteria on the 2013 Tokyo Guidelines (TG13) are used worldwide as the primary standard for management of acute cholangitis (AC), they need to be...